We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA, U.S. FDA Sign Transatlantic ‘Simplification’ Pact
EMEA, U.S. FDA Sign Transatlantic ‘Simplification’ Pact
July 15, 2008
The European Medicines Agency (EMEA) and the U.S. Food and Drug Administration (FDA) will collaborate on a range of projects aimed at simplifying and streamlining administrative practices and guidelines relating to drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor